iVoice Asked by FDA to Comment on Issues Related to the Accessibility of Pharmaceutical Information for Blind and Visually-Impaired Individuals


MATAWAN, N.J., June 8, 2004 (PRIMEZONE) -- iVoice, Inc. (OTCBB:IVOC), a leader in speech recognition technology, announced today that as a result of its recent patent application filings, the Company has been asked by the FDA to comment on issues related to the accessibility of pharmaceutical information for blind and visually-impaired individuals.

Section 107(f) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 requires that the Department of Health and Human Services conduct a study on how to make prescription pharmaceutical information accessible to blind and visually-impaired individuals. iVoice has been identified as a party who may hold a particular interest in this matter and therefore the FDA has brought to the Company's attention the publication of this Federal Register notice.

iVoice has recently filed two patents relating to the study: Methodology for Talking Prescription Bottle with Voice Instructions via Wireless Technology; and Methodology for Wirelessly Loading Over-the-Counter Medicine Containers with Voice Instructions through Wireless Technology.

iVoice, Inc. also reported today that it had recently completed an additional round of funding under its equity line. Since the beginning of 2004, iVoice has raised an additional $5.5 million, bringing its total cash reserves to approximately $9.4 million. Jerome Mahoney, President and Chief Executive Officer of iVoice, stated: "The Company's cash position has never been stronger. Clearly, we have the financial resources to fund the Company's cash needs for the foreseeable future. We anticipate these funds will be used for general working capital needs, financing future growth, strategic acquisitions and possible investment in other companies."

About iVoice, Inc.

iVoice, Inc. designs, manufactures and markets innovative voice and computer telephony communications systems for businesses and corporate departments. The Interactive Voice Response (IVR) products developed by iVoice allow information in PC databases to be accessed via voice or from a standard touch-tone telephone. The products are designed to be simple for the end user and provide a cohesive system to access messaging systems using your voice.

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to iVoice, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.


            

Contact Data